ENDOMETRIAL CARCINOMA
Clinical trials for ENDOMETRIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL CARCINOMA trials appear
Sign up with your email to follow new studies for ENDOMETRIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Off-the-Shelf immune cells take on Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests a new cancer treatment called FT836, a type of immune cell that is made in a lab and ready to use (off-the-shelf). It is given to people with advanced solid tumors like lung, colorectal, breast, ovarian, endometrial, or head and neck cancers that have…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: PHASE1 • Sponsor: Fate Therapeutics • Aim: Disease control
Last updated Jun 01, 2026 17:55 UTC
-
Genetic clues to stop endometrial cancer's return
Knowledge-focused Recruiting nowThis study looks at the genetics of high-risk endometrial cancer to find out why it sometimes returns after treatment. About 100 adults having surgery at Mayo Clinic will provide tissue and blood samples. Researchers will analyze these samples to build a databank for future studi…
Matched conditions: ENDOMETRIAL CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 11, 2026 12:11 UTC